Hôpital Maisonneuve-Rosemont is a hospital in Montreal, Quebec, Canada, located in the boroughs of Rosemont–La Petite-Patrie and Mercier-Hochelaga-Maisonneuve. It serves the eastern part of the city and offers 800 beds. It employs 5,000 people and 3,000 students annually.

There are 800 beds in Universite de Montreal - Hopital Maisonneuve-Rosemont.

During the past decade, Universite de Montreal - Hopital Maisonneuve-Rosemont conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universite de Montreal - Hopital Maisonneuve-Rosemont" #1 collaborator was "University of Sydney" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universite de Montreal - Hopital Maisonneuve-Rosemont" are "Cardiovascular Diseases" (1 trials), "Dialysis Related Complication" (1 trials), "End Stage Renal Disease" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Kidney Transplantation" (1 trials). Many other conditions were trialed in "Universite de Montreal - Hopital Maisonneuve-Rosemont" in a lesser frequency.

Most popular intervention types in "Universite de Montreal - Hopital Maisonneuve-Rosemont" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Giredestrant" (1 trials) and "Giredestrant-matched Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universite de Montreal - Hopital Maisonneuve-Rosemont" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universite de Montreal - Hopital Maisonneuve-Rosemont". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universite de Montreal - Hopital Maisonneuve-Rosemont, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universite de Montreal - Hopital Maisonneuve-Rosemont, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".